Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : 541400 | NSE Symbol : ZIMLAB | ISIN : INE518E01015 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

(04-Jun-25 17:05) Zim Laboratories AGM scheduled
(21-May-25 07:38) Zim Laboratories consolidated net profit declines 39.68% in the March 2025 quarter
(15-May-25 12:30) Zim Laboratories to announce Quarterly Result
(09-Apr-25 20:57) Zim Laboratories partners with UAE-based Globalpharma Co.
(20-Mar-25 12:53) Zim Labs gets regulatory nod in Portugal for multiple sclerosis treatment drug Dimethyl Fumarate
(11-Feb-25 08:05) Zim Laboratories consolidated net profit declines 16.32% in the December 2024 quarter
(04-Feb-25 15:18) Zim Laboratories to declare Quarterly Results
(11-Jan-25 09:56) ZIM Lab and Neuraxpharm announces grant of marketing authorization for "Buprenorphine Sublingual Film" in Europe
(16-Nov-24 12:56) Zim Laboratories incorporates step-down subsidiary in Dubai
(11-Nov-24 07:29) Zim Laboratories consolidated net profit declines 42.65% in the September 2024 quarter

1 2 3 4 5 6 7 8 9

Zim Laboratories Ltd